Drug Shortage Report for BIAXIN
Report ID | 149979 |
Drug Identification Number | 02244641 |
Brand name | BIAXIN |
Common or Proper name | CLARITHROMYCIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | CLARITHROMYCIN |
Strength(s) | 250MG |
Dosage form(s) | GRANULES FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 105ML |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-02-09 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2022-01-17 |
Shortage status | Avoided shortage |
Updated date | 2022-01-18 |
Company comments | Quality Hold |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-01-18 | French | Compare |
v7 | 2022-01-18 | English | Compare |
v6 | 2021-12-21 | French | Compare |
v5 | 2021-12-21 | English | Compare |
v4 | 2021-11-30 | French | Compare |
v3 | 2021-11-30 | English | Compare |
v2 | 2021-11-26 | French | Compare |
v1 | 2021-11-26 | English | Compare |
Showing 1 to 8 of 8